Found 4 matching trials
Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)
PHASE1The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Location
University of Mississippi Medical Center
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
PHASE2This study evaluates the efficacy and tolerability of treatment for T-lymph...
Location
Sun Yat-sen University Cancer Center
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PHASE1This study is about an anticancer drug called ponatinib which is a tyrosine...
Location
Arkansas Children's Hospital
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
PHASE1This study combines vyxeos and gilteritinib in patients with relapsed or re...
Location
Moffitt Cancer Center